drugset / Trial / NCT02810119

To Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Conjunctivochalasis

NCT02810119

Phase 2 Completed 13 enrolled Ocuwize LTD
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A Randomized, Double-Blind, Placebo-Controlled, Pilot Study to Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients with Moderate to Severe Conjunctivochalasis

Timeline

Start
2016-11
Primary completion
2017-10
Completion
2017-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Hyaluronate Other / unclassified Topical

Indications